Category: PrimeCuts

Clinical Correlations


ShortCuts: This Week in the Journals

PrimeCuts 2 min read

Shortcut JAMA reported on two important “negative” trials: The results of the EVEREST trial, comparing tolvaptan (a novel vasopressin V2 receptor blocker) to placebo for the treatment of acute CHF exacerbation, indicate that this agent had no effect on …

Read More

ShortCuts-This Week in the Journals

PrimeCuts 2 min read

Shortcut 2It seemed to be a slow week in the medical literature, but that will likely change as the 2007 American College of Cardiology Scientific Session is now underway. Theheart.org has an excellent summary about what to expect from the meetings. (free …

Read More

ShortCuts-This Week in the Journals

PrimeCuts 2 min read

ShortcutWelcome to ShortCuts, yet another new feature of Clinical Correlations. Every week we will post what we feelare the 5 most interesting articles from the news and literature with links. We’re not attempting to digest any of this for you or to be …

Read More